API Producer Presents Recent Additions to Commercial Product List

CPhI Worldwide is an excellent convention for meeting pharmaceutical industry professionals from all over the world in one location and the Rhodes Technologies team is looking forward to meeting friends and colleagues there.

In 2013, Rhodes added naloxone and methylphenidate to its commercial API product list and will be presenting these products to its customers at CPhI. In 2014, the Rhodes’s product list will grow again owing to the addition of several new products and the company will use this opportunity to evaluate commercial prospects for these products.

Rhodes staff will meet with existing, new and prospective customers to discuss how the company can help them with their API needs. They will also meet with Rhodes’s raw materials and intermediates suppliers and prospective suppliers to discuss the company’s current and future requirements.

Rhodes is an API manufacturer, with a cGMP facility located in the US in the state of Rhodes Island. This facility has been registered by the US Drug Enforcement Agency (DEA) for the R&D and manufacturing of controlled substances including opioids and cannabinoids. Rhodes imports narcotic raw materials for its manufacturing needs and supply our APIs to multiple customers both in the US and abroad, which manufacture large variety of drug products.

Rhodes is affiliated with a large international group of privately held companies.

Stand 51B57US

Rhodes Technologies, +1 401 262 9090, valeri.melekhov@pharma.com, www.rhodestec.com.